FDA Grants Approval to Atezolizumab for Alveolar Soft Part Sarcoma

by Yosef
December 17, 2022

FDA Grants Approval to Atezolizumab for Alveolar Soft Part Sarcoma

On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for […]
0
read more